Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Oncogene|February 14, 2003
Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activationEmanuela Roccato, Sonia Pagliardini, Loredana Cleris, et al.
Molecular Cancer Therapeutics|February 20, 2007
Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatmentMarina Bagnoli, Emanuela Balladore, Elena Luison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2011
Antitumor effects of a human dimeric antibody fragment 131I-AFRA-DFM5.3 in a mouse model for ovarian cancerAlberto Zacchetti, Franck Martin, Elena Luison, et al.
Biomedicines|December 24, 2021
Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused ReviewBarbara Frigerio, Elena Luison, Alessandro Desideri, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interactionFabio Turatti, Mariangela Figini, Emanuela Balladore, et al.
Anticancer Research|July 29, 2016
Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer PatientsLudmila Lozneanu, Patrizia Pinciroli, Delia Apostol Ciobanu, et al.
Cancer Research|February 5, 2003
The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinomaAntonella Tomassetti, Fabio Mangiarotti, Mimma Mazzi, et al.
Oncogene|August 25, 2004
A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processingAlessia Gaggero, Alessandro De Ambrosis, Delia Mezzanzanica, et al.
Pageof 12